Sonoma Pharmaceuticals, Inc.

0.17 USD
-0.00 (-0.98%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Sonoma Pharmaceuticals, Inc. stock is down -9.84% since 30 days ago. The next earnings date is Feb 13, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 52.94% of the previous 16 December’s closed higher than November.

About Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for various applications. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, a prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses. It also offers MicrocynAH, an HOCl-based solution designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites.